GeneDx Expands Exome and Genome Testing to Include Inborn Errors of Immunity GeneDx (Nasdaq: WGS), a leader in genomic diagnostics, has announced the expansion of its commercial focus to include Inborn Errors of Immunity (IEI). IEIs are a group of…
Morris & Dickson Expands 3PL Services with Presa Solutions Acquisition Morris & Dickson Inc., a prominent pharmaceutical wholesaler and specialty distributor, has announced its acquisition of Presa Solutions, a leading virtual third-party logistics (3PL) provider for pharmaceutical manufacturers. This acquisition…
Anaconda Biomed Enrolls First U.S. Patient in ATHENA Trial for ANA Funnel Catheter Anaconda Biomed, S.L., a company focused on developing advanced neuro thrombectomy devices, has announced the enrollment and treatment of the first U.S. patient in its ATHENA clinical…
eClinical Solutions: AI Adoption and Risk-Based Strategies in 2025 Clinical Trials eClinical Solutions LLC, a global provider of digital clinical software and services, has unveiled key insights from its 2025 Industry Outlook, an annual survey of clinical data experts from…
Utah Fertility Center Hires Dr. Erica Louden and Dr. Melinda Henne Ivy Fertility, a global network of renowned fertility clinics, is excited to announce the addition of Dr. Erica Louden and Dr. Melinda Henne to its team at Utah Fertility…
FDA Grants Paige Breakthrough Designation for AI Cancer Detection Across Sites Paige, a leader in next-generation AI technology, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to Paige PanCancer Detect*. This AI-assisted diagnostic…
Surmodics Launches Pounce™ XL Thrombectomy System for Rapid Clot Removal Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical devices and in vitro diagnostic technologies, has officially announced the commercial release of its Pounce™ XL Thrombectomy System. This new system…
Heart Rhythm Case Reports Publishes First Use of AI-Guided ECG Mapping for Left Bundle Branch Area Pacing Vektor Medical, a leader in non-invasive, AI-powered arrhythmia analysis technology, has announced the publication of a groundbreaking case report in Heart Rhythm Case…
AGC Biologics Launches Cellular and Genetic Technologies Division to Boost Nine Market-Approved Products AGC Biologics, a leading Contract Development and Manufacturing Organization (CDMO), has announced the creation of its new Cell and Gene Technologies division. This strategic move is designed…
Positive Phase 2 Alzheimer’s Study Data Published, Met Primary and Secondary Endpoints Sinaptica Therapeutics, Inc., a clinical-stage company pioneering personalized neuromodulation therapies for Alzheimer’s and other neurodegenerative diseases, has announced the publication of positive results from its 52-week Phase 2…
ELIQUENT Life Sciences Acquires Truliant Consulting to Expand Pharmacovigilance Platform ELIQUENT Life Sciences, a global leader in regulatory, quality, and safety consulting, has announced the strategic acquisition of Truliant Consulting, a highly regarded pharmacovigilance, risk management, and regulatory compliance advisory…
Johnson & Johnson Completes Intra-Cellular Therapies Acquisition to Strengthen Neuroscience Leadership Johnson & Johnson (NYSE: JNJ) has officially completed its acquisition of Intra-Cellular Therapies, Inc., further strengthening its position in the neuroscience sector. Intra-Cellular Therapies will now function as a…